Mylan’s hopes of grabbing a slice of the big US market for insulin glargine – the active ingredient in Sanofi’s Lantus blockbuster – have been dealt a blow. The FDA has issued a second ...
Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine ... The FDA approval was awarded to Mylan, which is now part of Viatris after merging with Pfizer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback